September 25–28, 2024, Amsterdam

European Academy of Dermatology and Venereology (EADV)

Poster icon

Early and long-term efficacy and safety of remibrutinib in patients with chronic spontaneous urticaria: 52-week data from the Phase 3 REMIX-1 and REMIX-2 studies

A.M. Giménez-Arnau, M. Metz, M. Hide, V. Jain, A. Khemis, M. Lebwohl, M. Palumbo, S. Saini, E. Şavk, G. Sussman, R. Szalewski, I.W. Herniczek, H. Windom, B. Yang, S. Haemmerle, K. Lheritier, Paula G.P. Machado, E-D. Martzloff, N. Seko, P. Wang, A. Zharkov, M. Maurer
Oral Presentation
Poster icon

Effect of remibrutinib treatment on disease activity in chronic spontaneous urticaria: Data from the Phase 3 REMIX-1 and
REMIX-2 studies

M. Metz, S. Saini, F. Berard, J. Reed, M. Maurer, S. Altrichter, C-Y. Chu, B. Suryawanshi, C-E. Ortmann, N. Chapman-Rothe, S. Haemmerle, J. Kern
e-Poster
Poster icon

CSU disease activity band shift after long-term treatment with remibrutinib in the Phase 3 REMIX-1 & REMIX-2 studies

M. Metz, A. M. Giménez-Arnau, P. Staubach, M.F. Puga, K. Kulthanan, X-H. Gao, K. Lheritier, C-E. Ortmann, N. Chapman-Rothe, S. Haemmerle, A. Fukunaga, M. Hide
e-Poster
Poster icon

Impact of remibrutinib on Dermatology-Related Quality of Life (DLQI) in patients with chronic spontaneous urticaria in the Phase 3 REMIX-1 and REMIX-2 studies

J. Reed, M. Metz, R. Saini, R. Szalewski, M. Lebwohl, M. Maurer, G. Sussman, S. Haemmerle, N. Seko, P. Wang, C. Field, M. J. Palumbo
e-Poster
Poster icon

Impact of chronic spontaneous urticaria on health-related quality of life domains: Country-specific data from patients participating in the Urticaria Voices study

T. A. Winders, J.A. Bernstein, J. McCarthy, P. Saraswat, N. Chapman-Rothe, T. Raftery, K. Weller
e-Poster
Poster icon

Physicians' perspective on the burden of CSU for patients and unmet need while treating CSU: Country-wide data from Urticaria Voices

J. A. Bernstein, T. A. Winders, J. McCarthy, P. Saraswat, N. Chapman-Rothe, T. Raftery, K. Weller
e-Poster
Poster icon

Utility scores in chronic spontaneous urticaria: A systematic literature review and statistical analysis

R. Kohli, E. Hawe, S. Harold, E. Simou, A. Chrysos, P. Orfanos
e-Poster
Novartis logo
Cookie Settings
© Copyright 2025 Novartis Pharma AG